Monaco Asset Management SAM »

Iovance Biotherapeutics shares owned by Monaco Asset Management SAM

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Monaco Asset Management SAM from 13F filings

Historical chart of Monaco Asset Management SAM investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Monaco Asset Management SAM consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Monaco Asset Management SAM

Quarter filed Position value Share count Share price at filing
2026-03-31 $790k 225k 3.51
2022-12-31 $735k 115k 6.39

More positions owned by Monaco Asset Management SAM

Micron Technology Put Option (MU)
Ishares Silver Tr Ishares (SLV)
Patterson-UTI Energy (PTEN)
Costco Wholesale Corporation Put Option (COST)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Teladoc (TDOC)
NVIDIA Corporation Put Option (NVDA)
Diageo Spon Adr New (DEO)
Viatris (VTRS)
Cibc Cad Put Option (CM)
Cosan S A Ads (CSAN)
Kosmos Energy (KOS)
Apple Put Option (AAPL)
I-80 Gold Corp *w Exp 11/16/202 (IAUX.WS)
Seadrill 2021 (SDRL)

View all positions for Monaco Asset Management SAM

Top funds holding Iovance Biotherapeutics

BlackRock
MHR Fund Management
Vanguard Group
State Street Corporation
Vanguard Capital Management
Two Sigma Investments
Vanguard Portfolio Management
Millennium Management
Goldman Sachs Group
Geode Capital Management
Invenomic Capital Management
Bank of America Corporation
D. E. Shaw & Co
Susquehanna International
Palo Alto Investors

View all funds holding Iovance Biotherapeutics